U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H6O3
Molecular Weight 174.1528
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JUGLONE

SMILES

OC1=CC=CC2=C1C(=O)C=CC2=O

InChI

InChIKey=KQPYUDDGWXQXHS-UHFFFAOYSA-N
InChI=1S/C10H6O3/c11-7-4-5-9(13)10-6(7)2-1-3-8(10)12/h1-5,12H

HIDE SMILES / InChI

Description

Juglone (5-hydroxy-1,4-naphthalenedione, C.I. Natural Brown 7, C.I. 75500) is an isomer of lawsone occurs naturally in the leaves, roots, husks, fruit (the epicarp), and bark of plants in the Juglandaceae family, particularly the black walnut (Juglans nigra). Juglone is an allelopathic compound, a substance that is produced by a plant to stunt the growth of another. Juglone is occasionally used as a herbicide. Traditionally, juglone has been used as a natural dye for clothing and fabrics, particularly wool, and as ink. Because of its tendency to create dark orange-brown stains, juglone has also found use as a coloring agent for foods and cosmetics, such as hair dyes. Juglone is currently being studied for its anticancer properties and It has been shown to decrease the probability of intestinal tumors in rats that have been exposed to carcinogens. One of the potential pathways through which juglone achieves its anticancer properties is through the formation of the semiquinone radical; the semiquinone radical causes superoxide anion radicals to form which can lead to apoptosis when present in large concentrations. This conversion from juglone to semiquinone radical that causes the superoxide anion radical to form takes place in the mitochondria as well as the cytosol.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
1.98 µM [IC50]
1.0 µM [IC50]
10.12 µM [IC50]
13.0 µM [IC50]
12.4 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Rats were treated with Juglone (i.v 0.1mg/kg; dermally 4mg/kg; oral 0.1, 1 or 10mg/kg)
Route of Administration: Other
In Vitro Use Guide
BEL-7402 cells were incubated in the presence of 12.5 micromol/L juglone for 24 h, and fixed in 2.5% glutaraldehyde for HE staining and Coomassie brilliant blue staining and scanning electron microscopy. Incubation with juglone resulted in obvious changes in the cell morphology and cytoskeletal alterations of the cells. Scanning electron microscopy revealed reduced volume of the cell bodies, dissociation of the cells, curling and malformation of the microvilli on the cell surface with rupture of the intercellular junction and enlargement of the intercellular space. The formation of apoptotic bodies was observed. Transmission electron microscopy showed expansion of the endoplasmic reticula, mitochondrial cristea disintegration, nucleolar fragmentation and formation of the apoptotic bodies after the exposure to juglone for 24 h.